Novotech | Competitive Intelligence Profile
Novotech is a global full-service clinical research organization (CRO) and scientific advisory partner, founded in 1997, specializing...
Novotech is a global full-service clinical research organization (CRO) and scientific advisory partner, founded in 1997, specializing in accelerating drug development for biotech and small to mid-sized pharmaceutical companies. It offers comprehensive services across all phases of clinical trials, including oncology, pharmacometrics, regulatory affairs, and data management, with a strong presence in the Asia-Pacific region, North America, and Europe. The company is recognized for its therapeutic expertise, client-centric approach, and awards such as the Frost & Sullivan CRO Company of the Year.
🛍️ Novotech Product and Pricing Intelligence →
📅 Novotech Event Participations →
⚖️ Novotech Regulatory Intelligence →
👔 Novotech Management and Leadership Team →
⚔️ Novotech Alternatives and Competitors →
💼 Novotech Hiring and Layoffs →
🤝 Novotech Partnerships, Clients and Vendors →
📈 Novotech Financial Performance, Fundraising, M&A →
🛍️ Novotech Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- Scott Schliebner, vice president and global head of Drug Development Consulting at Novotech, emphasized that high-quality data is essential for effective use of real-world evidence in clinical trials.
- Gab Silver, Therapeutic Strategy Manager at Novotech, explores how GLP-1 therapies raise the bar for obesity treatment and reveal gaps for next-generation innovation in a featured article.
📅 Novotech Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- Novotech's VP of Early Clinical Development Marina Mullins will host a workshop at RESI at JPM on the company's Early Clinical Development unit, featuring insights from Hansong (Andy) Liu and Carolyn Luscombe.
- Novotech's executives Hansong (Andy) Liu, Marina Mullins, and Carolyn Luscombe shared insights on early phase trials in Australia and China at RESI on January 12, and Dr. Judith Ng-Cashin, CMO, will speak at Fierce JPM on January 13.
- Novotech will participate in sessions at JPM 2026, including RESI on January 12 and Fierce JPM on January 13, featuring speakers like Hansong (Andy) Liu, Managing Director Greater China and Global Labs, Marina Mullins, VP Early Clinical Development, Carolyn Luscombe, Therapeutic Manager - Early Phase, and Dr. Judith Ng-Cashin, M.D., CMO.
⚖️ Novotech Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
👔 Novotech Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
CTO
[email protected] -
CFO[email protected]
-
Chairman and Chief Executive Officer[email protected]
-
Managing Director[email protected]
⚔️ Novotech Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- Parexel |
- George Clinical |
- Alexion |
- Regeneron Pharmaceuticals |
- Syneos Health |
- Celerion |
- Clinipace Worldwide |
- Covance |
- Agilex Biolabs |
- Avance Clinical |
- 360biolabs |
- Biorasi |
- Ask Gene Pharma |
- Altasciences |
- Australian Clinical Labs |
- Ergomed |
- Palm Beach CRO |
- Integrium |
- Landis+Gyr |
- Dotmatics |
- Tantalus |
- Massive Bio
💼 Novotech Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Anand Tharmaratnam has joined Novotech as Chairman and Chief Executive Officer in the United Kingdom, previously unspecified.
- Novotech appointed Dr. Anand Tharmaratnam as its new CEO on January 7, 2026, who previously served as the company's Chairman and brings nearly three decades of experience in the global CRO industry.
- Rachael Frazier has joined Novotech as Vice President Sales Operations in the United States, previously serving as Director, Contract & Proposal Strategy at RQM+.
🤝 Novotech Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
📈 Novotech Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
People also viewed
- Civic Marketplace |
- Prosper |
- Callosum |
- Facebook Competitor Insights: Boosting Key Account Win Rates with Strategic Intelligence |
- Orbital Materials |
- Pareto |
- Rivan Industries |
- Softmax |
- The Exploration Company |
- Karman+ |
- Mos |
- Relay
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense